Alto Neuroscience, Inc. (ANRO) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 184K | 0 | 0 | 100K | 0 | 170K | 0 | 0 | 97K | 92K | 0 |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -184K | 0 | 0 | -100K | 0 | -170K | 0 | 0 | -97K | -92K | 0 |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | 100% | - | - | 100% | -84.78% | - | - | - | - | - |
| Operating Expenses | 26.95M | -115.67M | 14.95M | 18.58M | 15.68M | 16.83M | 18.89M | 18.34M | 14.29M | 11.67M | 9.72M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 6.84M | 5.06M | 4.43M | 5.56M | 5.7M | 6.03M | 5.83M | 5.16M | 4.34M | 2.03M | 1.75M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 20.29M | 12M | 10.53M | 13.12M | 9.97M | 10.8M | 13.06M | 13.18M | 9.95M | 9.64M | 7.97M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | -184K | -1000K | 0 | -100K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -27.14M | 115.67M | -14.95M | -18.68M | -15.68M | -17M | -18.89M | -18.34M | -14.39M | -11.77M | -9.72M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -73.12% | 780.55% | 20.84% | -1.86% | -8.97% | -44.47% | -94.34% | - | - | - | - |
| EBITDA | -26.95M | 115.83M | -14.79M | -18.58M | -15.51M | -16.83M | -18.76M | -18.23M | -14.29M | -11.67M | -9.65M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -73.84% | 788.36% | 21.19% | -1.94% | -8.51% | -44.15% | -94.34% | - | - | - | - |
| D&A (Non-Cash Add-back) | 184K | 157K | 164K | 100K | 171K | 170K | 122K | 113K | 97K | 92K | 63K |
| EBIT | -27.14M | -15.61M | -13.53M | -17.06M | -14.57M | -14.87M | -16.43M | -15.68M | -13.07M | -10.86M | -8.78M |
| Net Interest Income | 1.02M | 986K | 882K | 1.04M | 1.23M | 1.8M | 2.15M | 2.31M | 1.21M | 382K | 351K |
| Interest Income | 1.56M | 1.56M | 1.53M | 1.68M | 1.83M | 2.13M | 2.5M | 2.66M | 1.56M | 738K | 714K |
| Interest Expense | 545K | 575K | 650K | 646K | 598K | 333K | 349K | 347K | 346K | 356K | 363K |
| Other Income/Expense | 901K | -131.85M | 770K | 976K | 507K | 1.8M | 2.1M | 2.31M | 969K | 548K | 577K |
| Pretax Income | -26.24M | -16.18M | -14.18M | -17.71M | -15.17M | -15.2M | -16.78M | -16.03M | -13.42M | -11.22M | -9.14M |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -26.24M | -16.18M | -14.18M | -17.71M | -15.17M | -15.2M | -16.78M | -16.03M | -13.42M | -11.22M | -9.14M |
| Net Margin % | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -72.96% | -6.45% | 15.5% | -10.46% | -13.06% | -35.52% | -83.6% | - | - | - | - |
| Net Income (Continuing) | -26.24M | -16.18M | -14.18M | -17.71M | -15.17M | -15.2M | -16.78M | -16.03M | -13.42M | -11.22M | -9.14M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.80 | -0.51 | -0.52 | -0.65 | -0.56 | -0.56 | -0.62 | -0.59 | -0.50 | -0.42 | -0.34 |
| EPS Growth % | -42.86% | 8.93% | 16.13% | -10.17% | -12% | -33.33% | -82.35% | - | - | - | - |
| EPS (Basic) | -0.80 | -0.51 | -0.52 | -0.65 | -0.56 | -0.56 | -0.62 | -0.59 | -0.50 | -0.42 | -0.34 |
| Diluted Shares Outstanding | 32.89M | 31.92M | 27.1M | 27.07M | 27.05M | 26.99M | 26.96M | 26.95M | 26.88M | 26.88M | 26.88M |
| Basic Shares Outstanding | 32.89M | 31.92M | 27.1M | 27.07M | 27.05M | 26.99M | 26.96M | 26.95M | 26.88M | 26.88M | 26.88M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - |